Dr. Steve Levine is a board-certified psychiatrist and internationally-recognized expert in the use of ketamine for psychiatric indications, amongst the first in the world to offer outpatient treatment. He graduated with honors/Phi Beta Kappa from Johns Hopkins University, received an academic scholarship to Tulane University School of Medicine, and then completed internship and residency in psychiatry at New York - Presbyterian Hospital - Weill Cornell. In addition, Dr. Levine completed fellowship subspecialty training in psychosomatic medicine/psycho-oncology at Memorial Sloan Kettering Cancer Center/New York Presbyterian Hospital. His free time is devoted to family, reading, and being humbled by Crossfit.
Who We Are
We are professionals advancing innovative healthcare using revolutionary treatments. Actify Neurotherapies’ mission is to improve mental health through the safe delivery of researched, proven, and innovative treatments.
As Featured In
OUR FOUNDER'S STORY
Steve Levine, MD
Founder & Chief Medical Officer (Board-Certified Psychiatrist)
Dr. Levine, a board-certified psychiatrist, founded Actify Neurotherapies as Ketamine Treatment Centers in 2011. Though he is a psychiatrist who places great emphasis on the importance of psychotherapy, medication is often a necessary component of treatment, and he was dissatisfied with the relatively ineffective available options with burdensome side effects. Dr. Levine pioneered a protocol for the clinical use of ketamine infusions, has directly supervised many thousands of infusions and has helped establish similar programs across the country and around the world. Along with significant growth, Actify maintains a commitment to provide evidence-based, compassion-driven advanced mental health care for the treatment-resistant community, starting with ketamine therapy.Learn More
We Make Lives Better
Providing hope through innovation, with nine locations and a growing presence in the mental health community, Actify Neurotherapies is the leading national mental health treatment practice in the country. Our ketamine specialists have treated thousands of patients since 2011 using industry leading methods and technology to achieve optimal results. Our experience is unsurpassed.Learn More
As the CEO of Actify Neurotherapies, Kathy Kaluhiokalani is responsible for running all facets of the business. She is passionate about providing access to next generation, best-in-class mental healthcare treatment for those dealing with major depressive and anxiety disorders. Prior to joining Actify Neurotherapies, Kathy was the Chief Operating Officer for MedExpress Urgent Care, an Optum Company. She was responsible for leading the center level operations of 250+ locations nationwide. Prior to MedExpress, Kathy worked for the University of Pittsburgh Medical Center (UPMC) in various roles for both Physician Services as well as Corporate Services. She earned her BA degree at the University of Maryland, Baltimore County, where she graduated summa cum laude. Kathy brings extensive healthcare leadership experience to Actify Neurotherapies and is excited to lead our mission of evidence based, compassion driven mental healthcare delivery.